Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Lulea

31 clinical trials in Lulea, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Lulea at a glance
31
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

31 trials in Lulea

Open in trial search

Cervix carcinoma

Recruiting

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm

General anaesthesia

Recruiting

Study on Low Oxygen and Nitrous Oxide Use During Anesthesia for Surgery Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Region Vaesterbotten

Diabetic foot

Recruiting

Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
  • Sponsor:University Of Gothenburg

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Misoprostol
  • Sponsor:University Of Gothenburg

Tonsillitis

Recruiting

Study on Phenoxymethylpenicillin for Patients with Severe Streptococcus Group A-Negative Acute Tonsillitis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benzathine Benzylpenicillin
  • Sponsor:Region Joenkoepings Laen

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Plasma cell myeloma

Recruiting

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Celgene Corp.

Urinary tract infection+1

Recruiting

Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Skane

Prophylaxis of nausea and vomiting

Not yet recruiting

Study of palonosetron and fosaprepitant to prevent nausea and vomiting after laparoscopic surgery

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Fosaprepitant
  • Sponsor:Region Vaesternorrland

Colorectal cancer

Not yet recruiting

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Region Skane

Chronic myeloid leukaemia

Not recruiting

Study on the Effectiveness and Safety of Ropeginterferon and Bosutinib for Patients with Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:St. Olavs Hospital HF

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Lulea

What the registry says about research in the country

01 Hematologic Oncology

Extensive research in Stockholm focusing on chronic lymphocytic leukemia (CLL) and various blood cancers, testing novel therapeutic combinations and treatment approaches.

  • Multiple Myeloma Treatment Studies
  • Leukemia Therapy Innovations
  • Lymphoma Management Strategies

Several trials evaluating combination therapies with drugs like ibrutinib, venetoclax, and rituximab for improved patient outcomes.

02 Preventive Medicine

Studies focused on prevention and early intervention, including a groundbreaking trial combining HPV vaccination and screening for cervical cancer elimination.

  • Cancer Prevention Protocols
  • Vaccination Strategies
  • Population Health Initiatives

Research aimed at developing more effective disease prevention strategies and improving public health outcomes.

03 Solid Tumor Research

Innovative studies examining treatments for non-small cell lung cancer and colorectal cancer, with focus on targeted therapies and personalized medicine approaches.

  • Targeted Cancer Therapies
  • Mutation-Specific Treatments
  • Immunotherapy Applications

Trials investigating novel therapeutic approaches for patients with specific genetic mutations and biomarkers.

Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.